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Abstract
Background: Probing the complex fusion of genetic and environmental interactions, metabolic profiling (or
metabolomics/metabonomics), the study of small molecules involved in metabolic reactions, is a rapidly expanding
‘omics’ field. A major technique for capturing metabolite data is
1H-NMR spectroscopy and this yields highly
complex profiles that require sophisticated statistical analysis methods. However, experimental data is difficult to
control and expensive to obtain. Thus data simulation is a productive route to aid algorithm development.
Results: MetAssimulo is a MATLAB-based package that has been developed to simulate
1H-NMR spectra of
complex mixtures such as metabolic profiles. Drawing data from a metabolite standard spectral database in
conjunction with concentration information input by the user or constructed automatically from the Human
Metabolome Database, MetAssimulo is able to create realistic metabolic profiles containing large numbers of
metabolites with a range of user-defined properties. Current features include the simulation of two groups (’case’
and ‘control’) specified by means and standard deviations of concentrations for each metabolite. The software
enables addition of spectral noise with a realistic autocorrelation structure at user controllable levels. A crucial
feature of the algorithm is its ability to simulate both intra- and inter-metabolite correlations, the analysis of which
is fundamental to many techniques in the field. Further, MetAssimulo is able to simulate shifts in NMR peak
positions that result from matrix effects such as pH differences which are often observed in metabolic NMR spectra
and pose serious challenges for statistical algorithms.
Conclusions: No other software is currently able to simulate NMR metabolic profiles with such complexity and
flexibility. This paper describes the algorithm behind MetAssimulo and demonstrates how it can be used to
simulate realistic NMR metabolic profiles with which to develop and test new data analysis techniques.
MetAssimulo is freely available for academic use at http://cisbic.bioinformatics.ic.ac.uk/metassimulo/.
Background
In the postgenomic era there has been a massive growth
in ‘omics’ techniques investigating different levels of bio-
logical organisation. Metabolic profiling (or metabo-
nomics/metabolomics) is a key area of systems biology
research focussing on high-throughput identification
and quantification of metabolites, small molecules
(≤1500 Da) involved in metabolism [1]. When trying to
relate genes to the overall function of a system, the
metabolome (the complete set of metabolites) more clo-
sely reflects the activities of the organism at a functional
level than, for example, the transcriptome [2]. Metabolic
fluxes are not only regulated by gene expression, but
also by additional factors, which include the abundance
of metabolites as substrates and products [3]. Therefore
metabolic profiling adds another dimension to our
understanding of biological systems.
A commonly used form of analysis in metabolic profiling
is
1H Nuclear Magnetic Resonance (NMR) spectroscopy of
biofluids. Metabolites in biofluids are in dynamic equili-
brium with those in cells and tissues so their metabolic
profile reflects changes in the state of an organism due to
disease or environmental effects.
1H-NMR spectroscopy
gives a global metabolic profile as it has the potential to
detect nearly all proton-containing metabolites. Despite
relatively poor sensitivity inc o m p a r i s o nw i t ha n a l y t i c a l
m e t h o d ss u c ha sm a s ss p e c t r o m e t r y ,N M Rs p e c t r o s c o p y
requires minimal sample preparation and is able to
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any medium, provided the original work is properly cited.measure concentrations as low as 100 μM[ 4 ]a n de v e n
lower with recent techniques such as cryoprobe technol-
ogy. NMR allows metabolites to be detected simulta-
neously without preselection. The NMR spectrum for each
metabolite is comprised of a characteristic pattern of peaks
or resonances, derived from three main factors:
1. The chemical shift (δ) of each resonance is depen-
dent upon the local magnetic field experienced by each
nucleus. This local field is dependent on the degree to
which molecular orbitals shield the influence of the
external spectrometer field. Thus the chemical shift can
reflect the chemical structure of the metabolite. The
position of each peak is measured relative to that of an
internal standard in a scale of parts per million (ppm) [5].
A commonly used internal standard is 3-(Trimethylsilyl)-
Propionic acid-D4, sodium salt (TSP).
2. Spin-spin coupling causes NMR resonances to split
into multiplet patterns due to magnetic interactions
between nearby nuclei.
3.Integrated peak area is proportional to the number
of observed
1H nuclei (assuming there are no differential
relaxation effects) and allows quantification of the meta-
bolite concentrations.
The NMR spectrum of a complex mixture can be well
approximmated by a linear combination of the spectra
of pure compounds, potentially thousands of metabo-
lites. Biofluid spectra can be treated as K dimensional
objects, in which each dimension represents the concen-
tration of a single metabolite [6]. This super-posed
structure is exploited in our simulation method, detailed
in the ‘Implementation’ section.
Metabolic NMR spectra are highly complex and the
field benefits greatly from the application of machine
learning and statistical tools to extract information.
Pattern recognition analyses such as Principal Compo-
nents Analysis (PCA) have long been combined with
NMR to investigate normal and pathological metabolic
states [7]. Data processing methods are being developed
to extract metabolite information and concentrations
from raw spectra, allowing automation of spectral proces-
sing. Development of advanced mathematical, statistical
and computational methods are also essential for charac-
terisation of the metabolic state, delineation of metabolic
changes over time and the efficient identification of
potential biomarkers. There are a wide variety of diseases
where key changes in metabolites have been deduced e.g.
cancer, diabetes, hypertension etc. [8-10]. However, as
algorithms and methods are developed, they need to be
refined and validated to ensure results will be biologically
meaningful. It is hard to effect this without using test
datasets where the true answers are known; this can be
accomplished using simulation techniques. An alternative
approach is to design artificial mixtures of metabolites
which are prepared and analysed in identical fashion to
real samples. However this is expensive in terms of man
power and instrument time, and offers few advantages
over in silico simulation when assessment of analytical
procedures is not required. The purpose of MetAssimulo
is to simulate datasets of realistic NMR spectra with
known parameters in order to test data analysis techni-
ques, hypotheses and experimental designs. Few methods
for generating simulated NMR datasets have appeared
i nt h el i t e r a t u r et od a t e[ 1 1 , 1 2 ] .M o s tm o d e lal i m i t e d
number of metabolites, make no attempt to reproduce
realistic levels of metabolites, and do not allow for
between-metabolite or ‘inter-metabolite’ correlations ([12]
excepted) and do not always model peak positional shifts.
It is common to fit Lorentzian peak shapes in an attempt
to characterize spectral peaks, e.g [11]. However, this
ignores the fact that peak shapes in real NMR profiles are
variable and can be far from ideal. Here we outline a novel
approach making use of individual standard metabolite
data extracted from the Human Metabolome Database
(HMDB) [13] and a local NMR standard spectra database
(NSSD). Many metabolic profiling labs host their own
NSSD appropriate to the biological systems and sample
types they work with and thus the simulations can be tai-
lored to virtually any sample type or organism as required.
In this work human urine is used as the example biofluid
as it is one of the most widely used in the field and, in
healthy subjects, has no protein or lipid content, both of
which make the simulation more complex. MetAssimulo
is written in MATLAB with a graphical interface allowing
the user to alter processing parameters and add new stan-
dard spectra as needed. The software is freely available
along with an example NSSD of 48 metabolites commonly
found in normal human urine. We stress that this list of
metabolites and their concentration means and standard
deviations does not constitute a definitive description of
human urine; such a goal is beyond the scope of this
paper. It is provided for the sole purpose of demonstrating
the capabilities of the software.
Implementation
MetAssimulo performs various functions accessed though
the Graphical User Interface (GUI): pre-processing the
pure spectra, simulating metabolite concentrations, incor-
porating peak shifts and creating the final mixture spec-
trum (Fig. 1). By default it produces two groups of spectra
based on different metabolite mixtures; these could repre-
sent controls (normal) and cases (diseased) subjects.
Each metabolite has a characteristic pattern of peaks
on a linear scale, the chemical shift, given by δ in ppm.
The signal intensity, y(δ), in a spectrum of metabolites
k (k = 1, .., K where K is the total number of metabolites
in the mixture) at a given δ increases proportionally to
the concentration of each metabolite, ck,p r e s e n ti nt h e
sample and their number of observed protons, pk.T h e
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Page 2 of 11different metabolite spectra are summed together to
produce the overall mixture spectrum. Normally distrib-
uted additive noise   () ()  N n 0
2 , (see ‘Calculate noise
standard deviation’ section for estimate of  n
2)i st h e n
added to the mixture spectrum (see Eqn.1), y(δ), which
is then smoothed to simulate the conventional prepro-
cessing technique of exponential apodization prior to
Fourier Transform [14].
yy c p k
K
kk k   () =∑ () () + () =1  (1)
Each individual metabolite spectrum is sampled at a
series of n uniformly spaced data points. The overall
spectrum is made up of pairs of data points, (x, y)=
(xi,yi)i = 1,..., n,w h e r eyi = y(xi); n is set by the user, and
xi defines a point on the ppm grid.
In real NMR spectra, the signal intensity is affected by
the extent to which the observed nuclei are allowed to
relax before each observation. In MetAssimulo we do
not currently attempt to simulate the effects of differen-
tial inter-molecular relaxation. However, intra-molecular
relaxation effects are accounted for by the fact that
experimentally obtained pure compound spectra are
used to form the mixture spectra.
Setting Parameters
Parameters can be altered either in the MetAssimulo
GUI or within the parameter file ‘parameters.txt’.
Default values for parameters are given in the Supple-
mentary Material. The interface provides the user with
several different processing options. For example the
second group (‘cases’) may be specified as fold change
ratios of the concentrations of the first group and the
user can specify whether to produce output with or
without peak shifts or both. The user also chooses
whether to include inter-metabolite correlation (pairwise
correlations between metabolites) or not; either as a
t e x t f i l ew h o s ee n t r i e sc a nb ea ltered using the interface
or constructed from scratch in the Correlation GUI.
Input Files
The Human Metabolome Database (HMDB) [13] con-
tains information about more than 2180 metabolites
found in humans and includes literature data relating to
normal and abnormal concentrations in biofluids. Meta-
bocards is the flat file download of the entire database,
available at http://www.hmdb.ca. Also required is the
HMDB set of NMR Peak Lists (containing locations of
individual peaks for metabolites) which is available in a
downloadable zip-file. In constructing the template of
normal human urine concentrations various problems of
incompleteness and/or ambiguity were encountered. For
example, in many HMDB entries the metabolite concen-
tration mean and standard deviation is unavailable, or
simply a range is given. In these cases the standard devia-
tion was estimated by dividing the mean (or ‘half-range’)
by 1.95. There are instances where a metabolite is identi-
fied as present in urine, but a normal concentration value
is not available. We have attempted to rectify as many of
these discrepancies as possible in the provided concen-
tration file by cross-checking with other sources, i.e.
literature articles, but do not claim the result represents a
complete description of human urine; it does, however
serve to demonstrate the software.
The quality of MetAssimulo simulations is also depen-
dent on the quality and coverage of the NSSD used, as
well as the peak shift settings affecting multiplet detec-
tion. By distributing an NSSD it is not our intention to
provide a comprehensive NMR standard database but
merely an initial set of common metabolite spectra with
which users can begin to make their own simulations.
Figure 1 MetAssimulo Structure.
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Page 3 of 11Many users will wish to add their own locally acquired
standard spectra for metabolites specific to their areas
of interest and we have provided functionality to do this.
There are a number of input files that are required for
MetAssimulo.
Concentration files* are needed for both groups of
metabolites, these detail the mean and standard devia-
tion of the concentration for each metabolite.
An NMR Standard Spectral Database (NSSD) com-
prising standard 1D
1H-NMR spectra for metabolites is
essential. MetAssimulo is designed to work with any
metabolite database set out in the Bruker file format.
Standard spectra of 48 of the most abundant metabolites
in normal human urine is distributed with MetAssimulo.
Experiment file identifying the experiments to use in
the metabolite database, as one metabolite may have
many spectra, taken at different pH for example.
Proton file listing the number of protons, pk observed
for each metabolite, k.
Multiplet data files* specifying the position of each
peak in a multiplet for each metabolite in order to
incorporate simulated peak shifts. Known pKa values
and acid/base limits can also be included.
Inter-metabolite correlations can be input via a text
file or the GUI.
Synonym files* that allow MetAssimulo to match
metabolites in the HMDB data to those in the NSSD.
Parameter file containing the default values or simu-
lation parameters (alterable in the GUI).
*Can be generated automatically using ‘Format HMDB
Data’ within MetAssimulo.
Examples of all input files in the appropriate format
are included with the MetAssimulo distribution. Much
of the required input data can be generated using the
in-built function ‘Format HMDB Data’ (accessed via the
GUI) which should be run as an initial ‘setup’.I tp r o -
duces the files necessary for conversion between the
local database and HMDB synonyms, data required for
peak shift simulation and a raw template of concentra-
tion data for ‘normal’ urine. The normal urine concen-
tration file provided with the distribution has been
optimized to provide realistic values and correct a num-
ber of errors found in the current version of the HMDB
whilst reducing the number of metabolites used in order
to decrease processing time.
Pre-processing
Initially, a set of metabolite concentrations is simulated
for the case and control groups, based on the mean and
standard deviations in the concentration file. Next, the
required spectra from the NSSD must be loaded. Even
1H-NMR spectra of standard pure compounds contain a
number of complexities, such as chemical and electronic
noise, phase and baseline errors, contaminants and
water suppression residuals. Thus it is ususally necessary
to preprocess these spectra into a form suitable for
combining into the final metabolic profiles.
Simulating Concentrations
Concentrations, ck, for each metabolite, k =1 ,. . ,K,a r e
simulated for the number of replicates specified by the
user. Individual metabolite concentrations are generated
from a truncated normal distribution, Eqn.2, using the
inverse cdf method since negative concentrations are
unphysical [15]. Here μ is the mean concentration and
s is the standard deviation input by the user.
cN I c kk   ,
2 0 () > () (2)
Significant inter-metabolite correlations, here assumed
to be linear pairwise correlations between metabolites,
are often found within the field of metabolic profiling so
were considered an important feature to incorporate into
the simulation. Where inter-metabolite correlations are
required, the concentrations are simulated by sampling
from the appropriate multivariate normal distribution.
Rejection sampling is utilised to ensure non-negative
concentrations. Using the method detailed in [16] the
nearest positive semidefinite correlation matrix is calcu-
lated given user-specified pairwise correlations. The cov-
ariance matrix is constructed using the metabolite
standard deviations and specified correlations, and the
diagonal entries are increased sufficiently to ensure posi-
tive-definiteness. Any necessary alterations to the corre-
lation and covariance matrices are output for inspection.
Read in spectrum
After the concentrations have been simulated the stan-
dard spectra of the metabolites are read in. Each spec-
trum consists of chemical shift in ppm, x and intensity,
y. Spectra are then linearly interpolated onto a ppm grid
of user-specified resolution.
Exclusion regions
Exclusion regions, corresponding to the location of the
internal standard peak (default < 0.2 ppm [17]) and the
residual water peak (default 4.5 ppm - 6.0 ppm [17]), are
set to zero. In urine, the urea signal (between 5.4 ppm
and 6.0 ppm [17]), the most abundant proton-containing
metabolite [6], can be problematic particularly when
water-suppression methods are used. Water-suppression
is usually imperfect and the resulting residual peaks (near
to the urea signal) are not dealt with easily by baseline
correction algorithms [18]. Often, the urea and water
peaks are combined into one exclusion region lying
between 4.5 ppm and 6 ppm (default exclusion region,
but can be adjusted by the user). Excluding these areas of
the spectrum helps reduce sensitivity to artifacts.
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Page 4 of 11Baseline Correction
It is easier to distinguish peaks in a spectrum when the
baseline is featureless [14], however, spectra can have
distorted baselines due to imperfections in the detection
process [17]. Curved baselines can be a major source of
error and so a correction is carried out on the raw spec-
trum using a moving average [19]. This method involves
splitting the data into windows of size ω (default is
0.3125 ppm), defined by the user, then using the median
within the window to estimate the baseline. In order to
alter the baseline without losing metabolite peaks, a
threshold is set by dividing the maximum height by a
user specified parameter (default is 10). All the intensi-
ties found below this threshold are corrected by sub-
tracting the estimated baseline.
Removal of Negative Artifacts
Negative artifacts, produced by baseline correction or
simply inherent in the original spectrum must be
removed since their presence could interfere with peaks
of interest in the mixture spectrum. This is remedied by
using an estimate of the noise standard deviation, smed,
to calculate a limit value, l, using Eqn.3. smed is esti-
mated by splitting the spectrum into a number of bins
(given by the user, default 32) and calculating their stan-
dard deviations. The median of these standard devia-
tions is used as the estimate of smed.
lM med =− 3 (3)
M is the median of the intensities, yi. All intensities
appearing below this limit,l, are set equal to it.
Kernel Smoothing
Noise from each standard metabolite spectrum will
remain in the final mixture spectrum, reducing the over-
all signal to noise ratio. Kernel smoothing is used to
reduce the noise in each individual metabolite spectrum.
This process estimates the smooth function underlying
the noisy data using a weighted mean of surrounding
data points with weights defined according to the choice
of kernel. Whilst the default kernel type is ‘Normal’,t h e
user may also choose from a number of options and
also alter the bandwidth (given as number of data
points), controlling the degree of smoothing required.
Since smoothing the whole spectrum woiuld increase
the peak widths, only intensities below a user-defined
threshold (a percentage of the maximum intensity,
default 0.8) are subject to kernel smoothing.
Peak Shift
If the user has chosen to simulate peak shifts (this is the
default setting), these are then calculated for each multi-
plet in each metabolite spectrum. First, a peak detection
process is used to identify peaks suitable for shifting. Peaks
detected are cross-referenced with the HMDB multiplet
data to determine those belonging to a multiplet that must
be shifted together. Whether or not a peak is shifted
depends on the user defined thresholds for peak detection,
and also its size relative to the noise. In real samples, peak
positional variation can derive from various matrix effects
primarily pH differences but also due to variation in the
concentration of other ionic species in the mixture. In
MetAssimulo, we take account of pH variation only; this is
sufficient to produce very realistic shift patterns and avoids
the need for many extra parameters in the model. If pKa
values and acid and base limits are not available, values
are drawn from normal distributions with user-specified
mean and standard deviation. If the user requires the same
pH for all replicates of a mixture, the pH value is set as the
user input. Otherwise, the pH values are sampled from a
normal distribution with mean and standard deviation
defined by the user. This information is then combined
using the Henderson-Hasselbalch Equation [5] (Eqn.4) to
calculate the peak shift (in ppm) and the peaks are shifted
accordingly.


ij
pH pKa
ij ij ij ij
pH pKa
ea b
e
j
j =
−− +
+
−
−
()
1
(4)
where δij is the un-shifted position of peak i of meta-
bolite j in ppm (known),
hij is the amount the peak is shifted in ppm (gener-
ated by Eq.4),
pH is the pH of sample (simulated or input),
pKaj is the pKa of metabolite j (simulated or input)
assumed here to be the same for all peaks of a given
metabolite,
aij is the position of peak i of metabolite j in the acid
limit (ppm) (simulated or input),
bij is the position of peak i of metabolite j in the basic
limit (ppm) (simulated or input).
After this process, the spectrum is then smoothed
again in order to suppress any unwanted artifacts cre-
ated by the peak shift.
Simulating Mixture Spectra
To make sure that all the metabolite spectra are on a
comparable scale the spectra are normalised to unit
integrated intensity, using Eqn.5.
y
y
y
i
i
i
n
i
=
∑ =

 1
(5)
where  yi is the intensity in the preprocessed, unnor-
malised standard spectrum.
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Page 5 of 11Calculate noise standard deviation
The final mixture spectrum is constructed using Eqn.1.
The standard deviation sn of noise to be added is calcu-
lated by dividing the maximum peak intensity by the
signal to noise ratio required by the user, SNR,a si n
Eqn.6.


n
y
SNR
= () () max (6)
Even after preprocessing, the signal to noise levels of the
individual metabolite spectra may vary, so therefore the
final signal to noise ratio cannot be controlled perfectly.
However, adding noise in this way allows the simulation of
mixture spectra with a wide variety of signal to noise
ratios. After adding the random noise, ε(δ)~N (0, sn),
kernel smoothing is used on the composite spectrum to
reproduce the effect of apodization on real spectra [14].
Results and Discussion
In this section some example outputs from MetAssi-
mulo will be shown. Simulations of normal urine were
run using the optimized template with parameters set to
the default values and using the NSSD consisting of 48
spectra recorded at 600 MHz
1H observation frequency.
Single Spectrum
To test whether MetAssimulo’s output spectra (Fig. 2(a))
seem realistic they are compared to a real normal human
urine spectrum with the same exclusion regions (Fig. 2
(b)). It should be noted that differences between real and
simulated spectra will result not only from the simula-
tion process, but also from incomplete knowledge of the
exact molecular species giving rise to NMR signals and
uncertainties in their levels. However, despite these diffi-
culties, the simulated and real spectra show many simila-
rities including the dominance of high abundance
metabolites such as creatinine, glycine, and citric
acid. The insets show how such realistic simulation
extends to low intensity signals of the aromatic region
such as hippurate, histidine, formate and N-methy-
lnicotinic acid.
Simulation of Case & Control Groups
W en o ws h o wh o wM e t A s s i m u l oc a np r o d u c et w o
groups of spectra with different metabolite compositions.
Figure 2 (a) Real normal urine sample, (b) Mean simulated normal urine sample.
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Page 6 of 11Figure 3 (a) Mean simulated normal urine spectrum, (b) Mean simulated spectrum of urine in paraquat poisoning.
Figure 4 (a) Scores plot of the first two principal components for the simulated data, (b) Loadings on PC1, (c) Loadings on PC2.
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Page 7 of 11Figure 5 Simulated peak shift for the two aromatic singlets of histidine.
Figure 6 Inter and intra-metabolite correlations: (i) Complete correlation matrix and insets (ii)-(v) showing strong negative inter-
metabolite correlation between citrate and creatinine and positive between 2-oxoglutarate and creatinine (ii), (iii) and strong positive
intra-metabolite correlations for creatinine (iv) and citrate (v). Colour scale indicates the level of Pearson correlation.
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eased state. Paraquat poisoning [20] was chosen as the
diseased state, from several available in the HMDB,
because it shows a diverse array of metabolic disregula-
tion in comparison with normal urine. The concentra-
tions of 4 metabolites are altered: citric acid and
creatinine are decreased, whilst alanine and lactic acid
are increased. Simulations were run for 50 replicates of
normal and diseased without peak shifts, the mean of
which are shown in Fig. 3. These spectra clearly show the
expected decrease in citric acid and creatinine concentra-
tions for Paraquat poisoning, whilst alanine and lactate
concentrations are increased. The PCA scores plot in
Fig. 4(a) clearly demonstrates separation in the first prin-
cipal component. The largest loadings on PC1, Fig. 4(b),
correspond to the metabolites that were altered, accu-
rately describing the difference between the two groups.
The largest loading on PC2 corresponds to glycine, the
metabolite with the highest with-group variance. This
data could be used in disease diagnostics to help train
machine learning methods in recognising disease status.
Peak Shifts
We demonstrate the peak shift using histidine, a metabo-
lite particularly prone to this kind of positional variation.
Acid and base limits were estimated by inspecting
spectra taken at varying pH values. Fig. 5 clearly shows
a shift in ppm values for this peak consistent with the
non-linear mechanism described by the Henderson-
Hasselbach Eqn.4.
Inter-Metabolite Correlations
To demonstrate the incorporation of inter-metabolite
correlations, we specify the pairwise Pearson correla-
tions of three metabolites: citrate, creatinine and
2-oxoglutarate. The following correlation matrix was
used.
citrate
creatinine
oxoglutarate
1
07 1
20 8 0 4 1
−
−−
⎛
⎝
⎜
⎜
⎜
⎞
⎠
⎟
⎟
⎟
.
..
This resulted in a positive definite covariance matrix,
so no adjustments were required. Fig. 6(i) visualizes the
correlation matrix between all spectral intensities. Most
correlations are close to zero as expected. The regions
enlarged in (ii)-(v) illustrate the the correlations that
were expected. The correlations can also be viewed in
Fig. 7 when the mean spectrum is coloured according to
Figure 7 Pairwise correlation coefficients mapped as a colour code onto the mean spectrum.C o r r e l a t i o n st o( a )c i t r a t e2 . 6 5p p m ,( b )
creatinine 4.08 ppm, (c) 2-oxoglutarate 2.44 ppm.
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chemical shift corresponding to a particular metabolite
peak position ((a) citrate-2.65 ppm, (b) creatinine-4.08
ppm, (c) 2-oxoglutarate-2.44 ppm). Note that these ana-
lyses are similar to the commonly used STOCSY [21]
technique which is used to analyse both inter- and
intra-metabolite correlations; our simulations could be
used to develop and test such methods.
Conclusions
There are currently simulation programs in different
areas of post-genomic science, such as SNP simulators
that are being used in whole genome association studies
[22,23]. MetAssimulo is a valuable addition to these
tools, enabling the simulation of realistic
1H NMR spec-
tra of complex biological mixtures including group-wise
variation, intermetabolite correlations and peak posi-
tional variation. However, there are areas which could
be enhanced. Any simulator of this kind is limited by
the sources of data available. The HMDB only contains
information about metabolite concentrations in humans,
therefore further user input or other metabolite data-
bases may be needed to address other organisms.
Human urine is the default setting for MetAssimulo, but
given the numerous alterable parameters, it is easy to
simulate profiles for other species and biofluids.
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